TreeWAS – Variant ID: rs9378127

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
L40 Psoriasis	1.000	0.000	0.000
L40.8 Other psoriasis	0.848	0.152	0.000
L40.0 Psoriasis vulgaris	0.836	0.164	0.000
J47 Bronchiectasis	0.000	0.184	0.816
J45.9 Asthma, unspecified	0.000	0.184	0.816
J45 Asthma	0.000	0.200	0.800
K90 Intestinal malabsorption	0.000	0.210	0.790
J40-J47 Chronic lower respiratory diseases	0.000	0.210	0.790
K90.9 Intestinal malabsorption, unspecified	0.000	0.259	0.741
L40.4 Guttate psoriasis	0.717	0.283	0.000
L40.3 Pustulosis palmaris et plantaris	0.717	0.283	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
L40.1 Generalised pustular psoriasis	0.717	0.283	0.000
E10.9 Without complications	0.000	0.353	0.647
E10 Insulin-dependent diabetes mellitus	0.000	0.356	0.644
E10.3 With ophthalmic complications	0.000	0.370	0.630
J42 Unspecified chronic bronchitis	0.000	0.376	0.624
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.608	0.392	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.600	0.400	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.590	0.410	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.589	0.411	0.000
T42.4 Benzodiazepines	0.588	0.412	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.415	0.585
J45.8 Mixed asthma	0.000	0.426	0.574
J45.1 Nonallergic asthma	0.000	0.426	0.574
K90.8 Other intestinal malabsorption	0.000	0.433	0.567
K90.3 Pancreatic steatorrhoea	0.000	0.433	0.567
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.433	0.567
K90.1 Tropical sprue	0.000	0.433	0.567
J41 Simple and mucopurulent chronic bronchitis	0.000	0.433	0.566
E10.1 With ketoacidosis	0.000	0.435	0.565
T43.3 Phenothiazine antipsychotics and neuroleptics	0.557	0.443	0.000
J45.0 Predominantly allergic asthma	0.000	0.445	0.555
L40-L45 Papulosquamous disorders	0.535	0.465	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.530	0.470	0.000
J43 Emphysema	0.000	0.475	0.524
E10.4 With neurological complications	0.000	0.476	0.524
T43.5 Other and unspecified antipsychotics and neuroleptics	0.520	0.480	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.482	0.518
E05.9 Thyrotoxicosis, unspecified	0.000	0.482	0.518
E00-E07 Disorders of thyroid gland	0.000	0.492	0.508
E10-E14 Diabetes mellitus	0.000	0.500	0.500
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.499	0.501	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.501	0.499
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.493	0.507	0.000
T43.2 Other and unspecified antidepressants	0.491	0.509	0.000
T42.1 Iminostilbenes	0.490	0.510	0.000
E10.0 With coma	0.000	0.510	0.489
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.512	0.488
E03 Other hypothyroidism	0.000	0.514	0.486
E10.5 With peripheral circulatory complications	0.000	0.515	0.485
T43.4 Butyrophenone and thioxanthene neuroleptics	0.483	0.517	0.000
J46 Status asthmaticus	0.000	0.520	0.480
E03.9 Hypothyroidism, unspecified	0.000	0.523	0.477
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.475	0.524	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.467	0.533	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.466	0.534	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.464	0.536	0.000
E10.7 With multiple complications	0.000	0.538	0.462
E10.6 With other specified complications	0.000	0.538	0.462
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.452	0.548	0.000
T42.0 Hydantoin derivatives	0.447	0.553	0.000
E10.8 With unspecified complications	0.000	0.554	0.446
T39.1 4-Aminophenol derivatives	0.446	0.554	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.436	0.564	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.436	0.564	0.000
T42.3 Barbiturates	0.436	0.564	0.000
T42.2 Succinimides and oxazolidinediones	0.436	0.564	0.000
L43 Lichen planus	0.435	0.565	0.000
T38.1 Thyroid hormones and substitutes	0.434	0.566	0.000
T36 Poisoning by systemic antibiotics	0.432	0.568	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.430	0.569	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.430	0.569	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.430	0.569	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.430	0.569	0.000
T43.6 Psychostimulants with abuse potential	0.424	0.576	0.000
T43.9 Psychotropic drug, unspecified	0.423	0.577	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.423	0.577	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.423	0.577	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.000	0.594	0.406
J41.1 Mucopurulent chronic bronchitis	0.000	0.594	0.406
J41.0 Simple chronic bronchitis	0.000	0.594	0.406
E07 Other disorders of thyroid	0.000	0.602	0.398
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.396	0.604	0.000
T45.0 Antiallergic and antiemetic drugs	0.395	0.605	0.000
E40-E46 Malnutrition	0.000	0.606	0.394
E65-E68 Obesity and other hyperalimentation	0.000	0.607	0.393
L44 Other papulosquamous disorders	0.384	0.616	0.000
L41 Parapsoriasis	0.384	0.616	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.384	0.616	0.000
L42 Pityriasis rosea	0.384	0.616	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.382	0.618	0.000
T38.9 Other and unspecified hormone antagonists	0.380	0.620	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.380	0.620	0.000
T38.7 Androgens and anabolic congeners	0.380	0.620	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.380	0.620	0.000
T38.5 Other oestrogens and progestogens	0.380	0.620	0.000
T38.4 Oral contraceptives	0.380	0.620	0.000
T38.2 Antithyroid drugs	0.380	0.620	0.000
T38.0 Glucocorticoids and synthetic analogues	0.380	0.620	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.380	0.620	0.000
L43.9 Lichen planus, unspecified	0.378	0.622	0.000
T39.0 Salicylates	0.377	0.623	0.000
J43.8 Other emphysema	0.000	0.624	0.376
J43.1 Panlobular emphysema	0.000	0.624	0.376
J43.0 MacLeod's syndrome	0.000	0.624	0.376
E10.2 With renal complications	0.000	0.626	0.374
E05.8 Other thyrotoxicosis	0.000	0.628	0.372
E05.5 Thyroid crisis or storm	0.000	0.628	0.372
E05.4 Thyrotoxicosis factitia	0.000	0.628	0.372
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.628	0.372
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.628	0.372
T50.9 Other and unspecified drugs, medicaments and biological substances	0.370	0.630	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.366	0.634	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.635	0.365
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.636	0.364
E00 Congenital iodine-deficiency syndrome	0.000	0.636	0.364
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.636	0.364
J43.9 Emphysema, unspecified	0.000	0.636	0.364
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.362	0.637	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.641	0.358
T39.4 Antirheumatics, not elsewhere classified	0.358	0.642	0.000
T39.2 Pyrazolone derivatives	0.358	0.642	0.000
T45.5 Anticoagulants	0.356	0.644	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.353	0.647	0.000
T45.8 Other primarily systemic and haematological agents	0.353	0.647	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.353	0.647	0.000
T45.6 Fibrinolysis-affecting drugs	0.353	0.647	0.000
T45.4 Iron and its compounds	0.353	0.647	0.000
T45.3 Enzymes, not elsewhere classified	0.353	0.647	0.000
T45.2 Vitamins, not elsewhere classified	0.353	0.647	0.000
J43.2 Centrilobular emphysema	0.000	0.651	0.349
E03.8 Other specified hypothyroidism	0.000	0.651	0.349
E03.5 Myxoedema coma	0.000	0.651	0.348
E03.4 Atrophy of thyroid (acquired)	0.000	0.651	0.348
E03.3 Postinfectious hypothyroidism	0.000	0.651	0.348
E03.1 Congenital hypothyroidism without goitre	0.000	0.651	0.348
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.651	0.348
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.346	0.654	0.000
J40 Bronchitis, not specified as acute or chronic	0.000	0.657	0.343
E65 Localised adiposity	0.000	0.664	0.336
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.335	0.665	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.335	0.665	0.000
T46.7 Peripheral vasodilators	0.335	0.665	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.335	0.665	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.335	0.665	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.335	0.665	0.000
T50.8 Diagnostic agents	0.334	0.666	0.000
T50.7 Analeptics and opioid receptor antagonists	0.334	0.666	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.334	0.666	0.000
T50.5 Appetite depressants	0.334	0.666	0.000
T50.4 Drugs affecting uric acid metabolism	0.334	0.666	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.334	0.666	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.334	0.666	0.000
T50.1 Loop [high-ceiling] diuretics	0.334	0.666	0.000
T50.0 Mineralocorticoids and their antagonists	0.334	0.666	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.332	0.667	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.332	0.667	0.000
T47.7 Emetics	0.332	0.667	0.000
T47.6 Antidiarrhoeal drugs	0.332	0.667	0.000
T47.5 Digestants	0.332	0.667	0.000
T47.4 Other laxatives	0.332	0.667	0.000
T47.3 Saline and osmotic laxatives	0.332	0.667	0.000
T47.2 Stimulant laxatives	0.332	0.667	0.000
T47.0 Histamine H(2)-receptor antagonists	0.332	0.667	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.668	0.332
T46.1 Calcium-channel blockers	0.326	0.674	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.674	0.326
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.324	0.676	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.322	0.678	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.320	0.680	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.316	0.684	0.000
L43.3 Subacute (active) lichen planus	0.312	0.688	0.000
L43.2 Lichenoid drug reaction	0.312	0.688	0.000
L43.1 Bullous lichen planus	0.312	0.688	0.000
L43.0 Hypertrophic lichen planus	0.312	0.688	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.311	0.689	0.000
T36.0 Penicillins	0.311	0.689	0.000
T36.9 Systemic antibiotic, unspecified	0.309	0.690	0.000
T36.8 Other systemic antibiotics	0.309	0.690	0.000
T36.7 Antifungal antibiotics, systemically used	0.309	0.690	0.000
T36.6 Rifamycins	0.309	0.690	0.000
T36.5 Aminoglycosides	0.309	0.690	0.000
T36.4 Tetracyclines	0.309	0.690	0.000
T36.3 Macrolides	0.309	0.690	0.000
T36.2 Chloramphenicol group	0.309	0.690	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.309	0.690	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.309	0.691	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.309	0.691	0.000
T37.5 Antiviral drugs	0.309	0.691	0.000
T37.4 Anthelminthics	0.309	0.691	0.000
T37.3 Other antiprotozoal drugs	0.309	0.691	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.309	0.691	0.000
T37.1 Antimycobacterial drugs	0.309	0.691	0.000
T37.0 Sulphonamides	0.309	0.691	0.000
T41.5 Therapeutic gases	0.309	0.691	0.000
T41.4 Anaesthetic, unspecified	0.309	0.691	0.000
T41.3 Local anaesthetics	0.309	0.691	0.000
T41.2 Other and unspecified general anaesthetics	0.309	0.691	0.000
T41.1 Intravenous anaesthetics	0.309	0.691	0.000
T41.0 Inhaled anaesthetics	0.309	0.691	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.309	0.691	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.309	0.691	0.000
T48.5 Anti-common-cold drugs	0.309	0.691	0.000
T48.4 Expectorants	0.309	0.691	0.000
T48.3 Antitussives	0.309	0.691	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.309	0.691	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.309	0.691	0.000
T48.0 Oxytocic drugs	0.309	0.691	0.000
T49.9 Topical agent, unspecified	0.309	0.691	0.000
T49.8 Other topical agents	0.309	0.691	0.000
T49.7 Dental drugs, topically applied	0.309	0.691	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.309	0.691	0.000
T49.5 Ophthalmological drugs and preparations	0.309	0.691	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.309	0.691	0.000
T49.3 Emollients, demulcents and protectants	0.309	0.691	0.000
T49.2 Local astringents and local detergents	0.309	0.691	0.000
T49.1 Antipruritics	0.309	0.691	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.309	0.691	0.000
E50-E64 Other nutritional deficiencies	0.000	0.695	0.305
E13 Other specified diabetes mellitus	0.000	0.699	0.301
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.286	0.714	0.000
E07.1 Dyshormogenetic goitre	0.000	0.715	0.285
E07.0 Hypersecretion of calcitonin	0.000	0.715	0.285
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.284	0.716	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.284	0.716	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.284	0.716	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.284	0.716	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.284	0.716	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.284	0.716	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.284	0.716	0.000
T44.0 Anticholinesterase agents	0.284	0.716	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.716	0.284
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.717	0.282
E45 Retarded development following protein-energy malnutrition	0.000	0.717	0.282
E43 Unspecified severe protein-energy malnutrition	0.000	0.717	0.282
E42 Marasmic kwashiorkor	0.000	0.717	0.282
E41 Nutritional marasmus	0.000	0.717	0.282
E40 Kwashiorkor	0.000	0.717	0.282
E67 Other hyperalimentation	0.000	0.718	0.281
E68 Sequelae of hyperalimentation	0.000	0.718	0.281
L43.8 Other lichen planus	0.281	0.719	0.000
E06 Thyroiditis	0.000	0.721	0.279
E16 Other disorders of pancreatic internal secretion	0.000	0.724	0.276
L41.9 Parapsoriasis, unspecified	0.275	0.725	0.000
L41.8 Other parapsoriasis	0.275	0.725	0.000
L41.5 Retiform parapsoriasis	0.275	0.725	0.000
L41.4 Large plaque parapsoriasis	0.275	0.725	0.000
L41.3 Small plaque parapsoriasis	0.275	0.725	0.000
L41.2 Lymphomatoid papulosis	0.275	0.725	0.000
L41.1 Pityriasis lichenoides chronica	0.275	0.725	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.275	0.725	0.000
L44.9 Papulosquamous disorder, unspecified	0.275	0.725	0.000
L44.8 Other specified papulosquamous disorders	0.275	0.725	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.275	0.725	0.000
L44.3 Lichen ruber moniliformis	0.275	0.725	0.000
L44.2 Lichen striatus	0.275	0.725	0.000
L44.1 Lichen nitidus	0.275	0.725	0.000
L44.0 Pityriasis rubra pilaris	0.275	0.725	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.727	0.273
E07.8 Other specified disorders of thyroid	0.000	0.738	0.262
E15 Nondiabetic hypoglycaemic coma	0.000	0.738	0.262
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.739	0.261
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.739	0.261
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.739	0.261
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.739	0.261
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.739	0.261
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.739	0.261
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.739	0.261
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.739	0.261
E14 Unspecified diabetes mellitus	0.000	0.739	0.261
E66 Obesity	0.000	0.742	0.258
E12.9 Without complications	0.000	0.743	0.257
E12.8 With unspecified complications	0.000	0.743	0.257
E12.7 With multiple complications	0.000	0.743	0.257
E12.6 With other specified complications	0.000	0.743	0.257
E12.5 With peripheral circulatory complications	0.000	0.743	0.257
E12.4 With neurological complications	0.000	0.743	0.257
E12.3 With ophthalmic complications	0.000	0.743	0.257
E12.2 With renal complications	0.000	0.743	0.257
E12.1 With ketoacidosis	0.000	0.743	0.257
E12.0 With coma	0.000	0.743	0.257
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.247	0.753	0.000
T40.6 Other and unspecified narcotics	0.244	0.756	0.000
E66.8 Other obesity	0.000	0.760	0.240
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.233	0.767	0.000
T40.8 Lysergide [LSD]	0.233	0.767	0.000
T40.7 Cannabis (derivatives)	0.233	0.767	0.000
T40.5 Cocaine	0.233	0.767	0.000
T40.3 Methadone	0.233	0.767	0.000
T40.1 Heroin	0.233	0.767	0.000
T40.0 Opium	0.233	0.767	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.776	0.224
E55 Vitamin D deficiency	0.000	0.776	0.224
E20-E35 Disorders of other endocrine glands	0.000	0.778	0.222
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.781	0.219
E63 Other nutritional deficiencies	0.000	0.781	0.219
E56 Other vitamin deficiencies	0.000	0.781	0.219
E51 Thiamine deficiency	0.000	0.781	0.219
E50 Vitamin A deficiency	0.000	0.781	0.219
E60 Dietary zinc deficiency	0.000	0.781	0.219
E59 Dietary selenium deficiency	0.000	0.781	0.219
E58 Dietary calcium deficiency	0.000	0.781	0.219
E54 Ascorbic acid deficiency	0.000	0.781	0.219
E52 Niacin deficiency [pellagra]	0.000	0.781	0.219
E13.8 With unspecified complications	0.000	0.784	0.216
E13.7 With multiple complications	0.000	0.784	0.216
E13.6 With other specified complications	0.000	0.784	0.216
E13.5 With peripheral circulatory complications	0.000	0.784	0.216
E13.4 With neurological complications	0.000	0.784	0.216
E13.3 With ophthalmic complications	0.000	0.784	0.216
E13.2 With renal complications	0.000	0.784	0.216
E13.1 With ketoacidosis	0.000	0.784	0.216
E13.0 With coma	0.000	0.784	0.216
E14.3 With ophthalmic complications	0.000	0.784	0.216
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.794	0.206
E44.1 Mild protein-energy malnutrition	0.000	0.797	0.203
E44.0 Moderate protein-energy malnutrition	0.000	0.797	0.203
E67.8 Other specified hyperalimentation	0.000	0.798	0.202
E67.3 Hypervitaminosis D	0.000	0.798	0.202
E67.2 Megavitamin-B6 syndrome	0.000	0.798	0.202
E67.1 Hypercarotenaemia	0.000	0.798	0.202
E67.0 Hypervitaminosis A	0.000	0.798	0.202
E04 Other non-toxic goitre	0.000	0.799	0.201
E06.5 Other chronic thyroiditis	0.000	0.800	0.200
E06.4 Drug-induced thyroiditis	0.000	0.800	0.200
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.800	0.200
E06.1 Subacute thyroiditis	0.000	0.800	0.200
E06.0 Acute thyroiditis	0.000	0.800	0.200
E53 Deficiency of other B group vitamins	0.000	0.800	0.200
J44 Other chronic obstructive pulmonary disease	0.000	0.801	0.199
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.802	0.198
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.802	0.198
E16.4 Abnormal secretion of gastrin	0.000	0.802	0.198
E16.3 Increased secretion of glucagon	0.000	0.802	0.198
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.802	0.198
E61 Deficiency of other nutrient elements	0.000	0.810	0.190
T40.2 Other opioids	0.188	0.812	0.000
E14.7 With multiple complications	0.000	0.812	0.187
E14.6 With other specified complications	0.000	0.812	0.187
E14.5 With peripheral circulatory complications	0.000	0.812	0.187
E14.4 With neurological complications	0.000	0.812	0.187
E14.2 Withrenal complications	0.000	0.812	0.187
E14.1 With ketoacidosis	0.000	0.812	0.187
E14.0 With coma	0.000	0.812	0.187
E21.3 Hyperparathyroidism, unspecified	0.000	0.813	0.187
E66.1 Drug-induced obesity	0.000	0.815	0.185
E16.1 Other hypoglycaemia	0.000	0.819	0.181
E66.2 Extreme obesity with alveolar hypoventilation	0.000	0.823	0.177
E14.8 With unspecified complications	0.000	0.824	0.176
E06.9 Thyroiditis, unspecified	0.000	0.826	0.174
T40.4 Other synthetic narcotics	0.173	0.827	0.000
E55.9 Vitamin D deficiency, unspecified	0.000	0.834	0.166
E04.2 Non-toxic multinodular goitre	0.000	0.835	0.165
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.838	0.162
E26 Hyperaldosteronism	0.000	0.838	0.162
E55.0 Rickets, active	0.000	0.839	0.161
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.840	0.159
E32 Diseases of thymus	0.000	0.840	0.159
E31 Polyglandular dysfunction	0.000	0.840	0.159
E30 Disorders of puberty, not elsewhere classified	0.000	0.840	0.159
E13.9 Without complications	0.000	0.841	0.159
E66.0 Obesity due to excess calories	0.000	0.841	0.158
E50.9 Vitamin A deficiency, unspecified	0.000	0.843	0.157
E50.8 Other manifestations of vitamin A deficiency	0.000	0.843	0.157
E50.7 Other ocular manifestations of vitamin A deficiency	0.000	0.843	0.157
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.000	0.843	0.157
E50.5 Vitamin A deficiency with night blindness	0.000	0.843	0.157
E50.4 Vitamin A deficiency with keratomalacia	0.000	0.843	0.157
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.000	0.843	0.157
E50.2 Vitamin A deficiency with corneal xerosis	0.000	0.843	0.157
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.000	0.843	0.157
E50.0 Vitamin A deficiency with conjunctival xerosis	0.000	0.843	0.157
E51.9 Thiamine deficiency, unspecified	0.000	0.843	0.157
E51.8 Other manifestations of thiamine deficiency	0.000	0.843	0.157
E51.2 Wernicke's encephalopathy	0.000	0.843	0.157
E51.1 Beriberi	0.000	0.843	0.157
E56.9 Vitamin deficiency, unspecified	0.000	0.843	0.157
E56.8 Deficiency of other vitamins	0.000	0.843	0.157
E56.1 Deficiency of vitamin K	0.000	0.843	0.157
E56.0 Deficiency of vitamin E	0.000	0.843	0.157
E63.9 Nutritional deficiency, unspecified	0.000	0.843	0.157
E63.8 Other specified nutritional deficiencies	0.000	0.843	0.157
E63.1 Imbalance of constituents of food intake	0.000	0.843	0.157
E63.0 Essential fatty acid [EFA] deficiency	0.000	0.843	0.157
E64.9 Sequelae of unspecified nutritional deficiency	0.000	0.843	0.157
E64.8 Sequelae of other nutritional deficiencies	0.000	0.843	0.157
E64.3 Sequelae of rickets	0.000	0.843	0.157
E64.2 Sequelae of vitamin C deficiency	0.000	0.843	0.157
E64.1 Sequelae of vitamin A deficiency	0.000	0.843	0.157
E64.0 Sequelae of protein-energy malnutrition	0.000	0.843	0.157
E21.0 Primary hyperparathyroidism	0.000	0.843	0.157
E06.3 Autoimmune thyroiditis	0.000	0.843	0.156
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.844	0.156
E22 Hyperfunction of pituitary gland	0.000	0.845	0.155
E28 Ovarian dysfunction	0.000	0.845	0.155
E27 Other disorders of adrenal gland	0.000	0.848	0.152
E29 Testicular dysfunction	0.000	0.852	0.148
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.852	0.148
E21.4 Other specified disorders of parathyroid gland	0.000	0.852	0.148
E21.2 Other hyperparathyroidism	0.000	0.852	0.148
E34 Other endocrine disorders	0.000	0.854	0.146
E04.8 Other specified non-toxic goitre	0.000	0.855	0.145
E53.9 Vitamin B deficiency, unspecified	0.000	0.857	0.143
E53.1 Pyridoxine deficiency	0.000	0.857	0.143
E53.0 Riboflavin deficiency	0.000	0.857	0.143
M07.39 Other psoriatic arthropathies (Site unspecified)	0.142	0.858	0.000
M07.3 Other psoriatic arthropathies	0.141	0.859	0.000
E20 Hypoparathyroidism	0.000	0.860	0.139
M07.30 Other psoriatic arthropathies (Multiple sites)	0.139	0.861	0.000
E61.9 Deficiency of nutrient element, unspecified	0.000	0.863	0.137
E61.8 Deficiency of other specified nutrient elements	0.000	0.863	0.137
E61.7 Deficiency of multiple nutrient elements	0.000	0.863	0.137
E61.6 Vanadium deficiency	0.000	0.863	0.137
E61.5 Molybdenum deficiency	0.000	0.863	0.137
E61.4 Chromium deficiency	0.000	0.863	0.137
E61.3 Manganese deficiency	0.000	0.863	0.137
E61.2 Magnesium deficiency	0.000	0.863	0.137
E61.0 Copper deficiency	0.000	0.863	0.137
E25 Adrenogenital disorders	0.000	0.865	0.135
E27.1 Primary adrenocortical insufficiency	0.000	0.866	0.134
E24 Cushing's syndrome	0.000	0.868	0.132
E27.9 Disorder of adrenal gland, unspecified	0.000	0.870	0.130
E53.8 Deficiency of other specified B group vitamins	0.000	0.876	0.124
M07.36 Other psoriatic arthropathies (Lower leg)	0.118	0.882	0.000
E26.0 Primary hyperaldosteronism	0.000	0.882	0.118
E22.1 Hyperprolactinaemia	0.000	0.882	0.118
E26.9 Hyperaldosteronism, unspecified	0.000	0.884	0.116
E26.8 Other hyperaldosteronism	0.000	0.884	0.116
E26.1 Secondary hyperaldosteronism	0.000	0.884	0.116
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.116	0.884	0.000
E30.9 Disorder of puberty, unspecified	0.000	0.885	0.114
E30.8 Other disorders of puberty	0.000	0.885	0.114
E30.1 Precocious puberty	0.000	0.885	0.114
E30.0 Delayed puberty	0.000	0.885	0.114
E31.9 Polyglandular dysfunction, unspecified	0.000	0.885	0.114
E31.8 Other polyglandular dysfunction	0.000	0.885	0.114
E31.1 Polyglandular hyperfunction	0.000	0.885	0.114
E31.0 Autoimmune polyglandular failure	0.000	0.885	0.114
E32.9 Disease of thymus, unspecified	0.000	0.885	0.114
E32.8 Other diseases of thymus	0.000	0.885	0.114
E32.1 Abscess of thymus	0.000	0.885	0.114
E32.0 Persistent hyperplasia of thymus	0.000	0.885	0.114
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.885	0.114
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.885	0.114
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.885	0.114
E04.1 Non-toxic single thyroid nodule	0.000	0.888	0.112
E28.3 Primary ovarian failure	0.000	0.888	0.112
E22.0 Acromegaly and pituitary gigantism	0.000	0.889	0.111
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.889	0.111
E22.8 Other hyperfunction of pituitary gland	0.000	0.889	0.111
E28.9 Ovarian dysfunction, unspecified	0.000	0.889	0.111
E28.8 Other ovarian dysfunction	0.000	0.889	0.111
E28.1 Androgen excess	0.000	0.889	0.111
E28.0 Oestrogen excess	0.000	0.889	0.111
E27.5 Adrenomedullary hyperfunction	0.000	0.890	0.109
E27.0 Other adrenocortical overactivity	0.000	0.890	0.109
E61.1 Iron deficiency	0.000	0.892	0.108
E29.9 Testicular dysfunction, unspecified	0.000	0.893	0.106
E29.8 Other testicular dysfunction	0.000	0.893	0.106
E29.0 Testicular hyperfunction	0.000	0.893	0.106
E28.2 Polycystic ovarian syndrome	0.000	0.895	0.105
E34.8 Other specified endocrine disorders	0.000	0.895	0.104
E34.5 Androgen resistance syndrome	0.000	0.895	0.104
E34.4 Constitutional tall stature	0.000	0.895	0.104
E34.3 Short stature, not elsewhere classified	0.000	0.895	0.104
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.895	0.104
E34.1 Other hypersecretion of intestinal hormones	0.000	0.895	0.104
E34.0 Carcinoid syndrome	0.000	0.895	0.104
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.897	0.103
M07.38 Other psoriatic arthropathies (Other)	0.101	0.899	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.101	0.899	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.101	0.899	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.101	0.899	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.101	0.899	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.101	0.899	0.000
E20.8 Other hypoparathyroidism	0.000	0.900	0.100
E20.1 Pseudohypoparathyroidism	0.000	0.900	0.100
E20.0 Idiopathic hypoparathyroidism	0.000	0.900	0.100
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.902	0.098
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.902	0.098
E25.9 Adrenogenital disorder, unspecified	0.000	0.903	0.097
E25.8 Other adrenogenital disorders	0.000	0.903	0.097
E29.1 Testicular hypofunction	0.000	0.905	0.095
E24.8 Other Cushing's syndrome	0.000	0.905	0.095
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.905	0.095
E24.3 Ectopic ACTH syndrome	0.000	0.905	0.095
E24.1 Nelson's syndrome	0.000	0.905	0.095
E24.0 Pituitary-dependent Cushing's disease	0.000	0.905	0.095
E27.8 Other specified disorders of adrenal gland	0.000	0.906	0.094
E34.9 Endocrine disorder, unspecified	0.000	0.909	0.091
E04.0 Non-toxic diffuse goitre	0.001	0.910	0.090
E04.9 Non-toxic goitre, unspecified	0.000	0.910	0.090
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.915	0.085
E24.9 Cushing's syndrome, unspecified	0.000	0.916	0.084
M06.9 Rheumatoid arthritis, unspecified	0.000	0.916	0.084
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.917	0.083

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations